DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Noxafil (Posaconazole) - Adverse Event Reports - Hospitalization

 



Index of reports > Cases resulting in hospitalization (22)

     Acute Hepatic Failure (5)Respiratory Arrest (5)Haemoptysis (4)Disseminated Intravascular Coagulation (4)Pneumonia Bacterial (4)Confusional State (3)Pneumonia (3)Somnolence (3)Haemodialysis (3)Metabolic Disorder (3)

Below is the selection of adverse event reports related to Noxafil (Posaconazole) that includes cases resulting in hospitalization.

Adverse event in female receiving Noxafil (Posaconazole)

Reported by a physician from France on 2007-10-12

Patient: female

Adverse reactions / side effects: Acute Generalised Exanthematous Pustulosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Phototherapy; Vfend



Adverse event in 9 year old female receiving Noxafil (Posaconazole)

Reported by a physician from France on 2007-10-01

Patient: 9 year old female

Adverse reactions / side effects: Hyponatraemia, Coma, Depressed Level of Consciousness, Metabolic Disorder, Somnolence, Convulsion

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Noxafil
    Indication: Fungal Infection
    Start date: 2007-06-01
    End date: 2007-07-02

Oncovin
    Dosage: 1800 mcg; qd; iv
    Indication: Chemotherapy
    Start date: 2007-06-15
    End date: 2007-06-16

Kidrolase (Asparaginase)
    Dosage: 25000 iu; once; im
    Indication: Chemotherapy
    Start date: 2007-06-16
    End date: 2007-06-16

Cytarabine
    Dosage: ; inth
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-06-10
    End date: 2007-06-10

Methotrexate
    Dosage: 120 mcg; once; iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-06-15
    End date: 2007-06-15

Other drugs received by patient: Nubain



Adverse event in 74 year old male receiving Noxafil (Posaconazole)

Reported by a individual with unspecified qualification from Spain on 2007-07-25

Patient: 74 year old male

Adverse reactions / side effects: Nasopharyngitis, Drug Ineffective, Pseudomonas Infection, Drug Interaction, General Physical Health Deterioration, Septic Shock

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Carduran NEO (Con.); Urbal (Con.); Amchafibrin (Con.); Aprovel (Con.); Seguril (Con.); Vitamin K (Con.); Duphalac (Con.); Aldactone (Con.); Finasteride (Con.); Targocid (Con.); Zyloric (Con.); Fluidasa (Con.); Albumin (Con.); Folic Acid (Con.); Danatrol (Prev.); Proscar (Prev.); Carduran NEO (Prev.); Dilutol (Prev.); Acovil (Prev.); Zyloric (Prev.); Voriconazole (Con.); Caspofungin (Con.)



Adverse event in 68 year old female receiving Noxafil (Posaconazole)

Reported by a physician from Germany on 2007-07-06

Patient: 68 year old female

Adverse reactions / side effects: Hypovolaemic Shock, Haemoptysis, Coagulopathy, Disseminated Intravascular Coagulation, Pulmonary Embolism, Hepatocellular Damage, Haemodialysis, Multi-Organ Failure, Capillary Leak Syndrome, Hepatotoxicity, Acute Hepatic Failure, Diffuse Alveolar Damage

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Levofloxacin; Tegretol; Liskantin; Magno Sanol; Kalinor RET; Carmustine; Cytarabine; Etoposide; Melphalan; Palifermin; Ambisome; Cancidas; Diflucan; Vfend; Acyclovir; Clexane



Adverse event in female receiving Noxafil (Posaconazole)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-06-19

Patient: female, weighing 48.1 kg (105.8 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Hypovolaemic Shock, Pruritus, Disseminated Intravascular Coagulation, Prothrombin Time Prolonged, Pyrexia, B-Cell Lymphoma Stage III, Metabolic Disorder, Lung Injury, Bronchopulmonary Aspergillosis, Pneumonia, Blood Lactate Dehydrogenase Increased, General Physical Health Deterioration, Haemolysis, Fungal Infection, Aspartate Aminotransferase Increased, Disturbance in Attention, Colon Polypectomy, Hypersensitivity, Endometriosis, Osteoporosis, Chills, Salpingo-Oophorectomy, Somnolence, Polyneuropathy, Chest X-RAY Abnormal, Stem Cell Transplant, Capillary Leak Syndrome, Fatigue, Gamma-Glutamyltransferase Increased, Thyroidectomy, Liver Function Test Abnormal, Pleural Effusion, Antithrombin III Decreased, Thrombocytopenia, Haptoglobin Decreased, Haemoptysis, Laparoscopic Sterilisation, Rash, Varicose Vein, T-Cell Lymphoma Stage III, Osteoarthritis, Renal Failure, Diarrhoea, Cardiac Failure, Sepsis, Acute Hepatic Failure, Asthenia, Venous Stent Insertion, Infection

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Tegretol
    Dosage: 200 mg/day
    Administration route: Oral

Noxafil
    Dosage: unk, unk
    Start date: 2006-12-15
    End date: 2006-12-20

Other drugs received by patient: Cytarabine; Cytarabine; Rituximab; Cisplatin; Dexamethasone 0.5mg TAB; Carmustine; Etoposide; Melphalan; Liskantin; Kalinor Retard; Ambisome; Ambisome; Ambisome; Ambisome; Cancidas; Cancidas; Cancidas; Diflucan; Vfend; Acyclovir; Clexane; Palifermin; Palifermin; Tavanic



Adverse event in female receiving Noxafil (Posaconazole)

Reported by a physician from Germany on 2007-05-15

Patient: female, weighing 48.1 kg (105.8 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Pruritus, Disseminated Intravascular Coagulation, Prothrombin Time Prolonged, Pyrexia, Chemotherapy, B-Cell Lymphoma Stage III, Metabolic Disorder, Bronchopulmonary Aspergillosis, Pneumonia, Blood Lactate Dehydrogenase Increased, General Physical Health Deterioration, Haemolysis, Fungal Infection, Aspartate Aminotransferase Increased, Disturbance in Attention, Colon Polypectomy, Hypersensitivity, Osteoporosis, Endometriosis, Chills, Salpingo-Oophorectomy, Somnolence, Chest X-RAY Abnormal, Polyneuropathy, Stem Cell Transplant, Fatigue, Gamma-Glutamyltransferase Increased, Thyroidectomy, Liver Function Test Abnormal, Pleural Effusion, Thrombocytopenia, Antithrombin III Decreased, Haptoglobin Decreased, Haemoptysis, Laparoscopic Sterilisation, Rash, Varicose Vein, T-Cell Lymphoma Stage III, Osteoarthritis, Diarrhoea, Sepsis, Acute Hepatic Failure, Asthenia, Venous Stent Insertion, Infection

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Tegretol
    Dosage: 200 mg/day
    Administration route: Oral

Noxafil
    Dosage: unk, unk
    Start date: 2006-12-15
    End date: 2006-12-20

Other drugs received by patient: Arac; Arac; Rituximab; Cisplatin; Dexamethasone 0.5mg TAB; Carmustine; Etoposide; Melphalan; Liskantin; Kalinor Retard; Ambisome; Ambisome; Ambisome; Ambisome; Cancidas; Cancidas; Cancidas; Diflucan; Vfend; Acyclovir; Clexane; Palifermin; Palifermin; Tavanic



Adverse event in 38 year old female receiving Noxafil (Posaconazole)

Reported by a physician from Belgium on 2007-05-07

Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)

Adverse reactions / side effects: Pneumonia Bacterial, Respiratory Arrest, Acute Respiratory Failure

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Posaconazole (Prev.); Prograft (Con.); Sulfadiazine (Con.); Medrol / 00049601 / (Con.); Meronem / 01250501 / (Con.)



Adverse event in 38 year old female receiving Noxafil (Posaconazole)

Reported by a physician from Belgium on 2007-04-23

Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)

Adverse reactions / side effects: Pneumonia Fungal, Pneumonia Bacterial, Respiratory Arrest, Condition Aggravated, Acute Respiratory Failure

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Posaconazole; Prograf; Sulfadiazine; Medrol; Meronem / 01250501 /



Adverse event in 51 year old female receiving Noxafil (Posaconazole)

Reported by a pharmacist from United States on 2007-04-20

Patient: 51 year old female, weighing 58.1 kg (127.8 pounds)

Adverse reactions / side effects: Hepatitis Acute

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Thalidomide; High Dose Dexamethasone; Melphalan; Toprol-XL; Topamax; Gemfibrozil; Nexium; Xanax; Percocet; Effexor



Adverse event in 7 year old male receiving Noxafil (Posaconazole)

Reported by a pharmacist from United States on 2007-04-18

Patient: 7 year old male, weighing 28.0 kg (61.6 pounds)

Adverse reactions / side effects: Disease Recurrence, Aspergillosis, Condition Aggravated, Pancreatitis, Pulmonary Mass

Adverse event resulted in: hospitalization

Suspect drug(s):
Noxafil
    Dosage: see image
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2007-03-11
    End date: 2007-03-11

Noxafil
    Dosage: see image
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2007-03-15
    End date: 2007-03-16

Noxafil
    Dosage: see image
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2007-03-17
    End date: 2007-03-25

Noxafil
    Dosage: see image
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2007-03-26

Other drugs received by patient: Meropenem (Con); Voriconazole (Prev)



Adverse event in 38 year old female receiving Noxafil (Posaconazole)

Reported by a physician from Belgium on 2007-04-09

Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)

Adverse reactions / side effects: Pneumonia Fungal, Respiratory Failure, Pneumonia Bacterial, Respiratory Arrest, Carbon Dioxide Increased, Lung Abscess, Inflammation

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Posaconazole (Prev.); Prograft (Con.); Sulfadiazine (Con.)



Adverse event in 38 year old female receiving Noxafil (Posaconazole)

Reported by a physician from Belgium on 2007-04-04

Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)

Adverse reactions / side effects: Respiratory Failure, Pneumonia Bacterial, Respiratory Arrest

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Posaconazole; Prograf; Sulfadiazine



Adverse event in 59 year old female receiving Noxafil (Posaconazole)

Reported by a physician from France on 2007-03-28

Patient: 59 year old female, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Confusional State, Depression, Disorientation, Memory Impairment

Adverse event resulted in: hospitalization

Suspect drug(s):
Noxafil
    Dosage: 1 df;bid;po
    Administration route: Oral
    Indication: Aspergillosis

Prednisone
    Dosage: 10 mg;qd;po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-10-05

Fungizone
    Dosage: 1 df;tid;po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Lexomil (Bromazepam)
    Dosage: 1 df;qd;po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Zelitrex (NO Pref. Name)
    Dosage: 500 mg;qd;po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Neoral
    Dosage: 50 mg;bid;po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-10-05

Phenoxymethylpenicillin
    Dosage: 2 df;qd;
    Indication: Drug USE FOR Unknown Indication

Bactrim DS
    Dosage: 1 df; tiw;
    Indication: Drug USE FOR Unknown Indication

Omeprazole
    Dosage: 20 mg;qd
    Indication: Drug USE FOR Unknown Indication

Lederfoline (NO Pre. Name)
    Dosage: 25 mg;qw
    Indication: Drug USE FOR Unknown Indication

Diantalvic (DI-Gesic)
    Indication: Drug USE FOR Unknown Indication

Morphine
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-12-18
    End date: 2006-12-25

Fludarabine Phosphate
    Indication: Drug USE FOR Unknown Indication

Anesthesics NOS (NO Pref. Name)
    Indication: Drug USE FOR Unknown Indication



Adverse event in 38 year old female receiving Noxafil (Posaconazole)

Reported by a physician from Belgium on 2007-03-27

Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)

Adverse reactions / side effects: Pneumonia, Respiratory Failure, Respiratory Arrest, Inflammation

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Posaconazole (Prev.)



Adverse event in 73 year old male receiving Noxafil (Posaconazole)

Reported by a physician from France on 2007-03-26

Patient: 73 year old male, weighing 80.0 kg (176.0 pounds)

Adverse reactions / side effects: Weight Increased, Face Oedema, Fluid Retention, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Levothyrox (Con.); Amiodaron (Con.); Ambisone (Con.)



Adverse event in 68 year old female receiving Noxafil (Posaconazole)

Reported by a physician from Germany on 2007-03-12

Patient: 68 year old female

Adverse reactions / side effects: Drug Toxicity, Haemoptysis, Disseminated Intravascular Coagulation, Acute Hepatic Failure, Hepatocellular Damage, Haemolysis, Haemodialysis

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Tavanic; Tegretol; Liskantin; Magno Sanol; Kalinor RET; Carmustine; Arac; Etoposide; Melphalan; Palifermin; Ambisome; Diflucan; Vfend; Acyclovir; Clexane



Adverse event in 59 year old female receiving Noxafil (Posaconazole)

Reported by a physician from France on 2007-03-02

Patient: 59 year old female, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Confusional State, Memory Impairment, Depression, Disorientation

Adverse event resulted in: hospitalization

Suspect drug(s):
Noxafil
    Dosage: 1 df; bid;po
    Administration route: Oral
    Indication: Aspergilloma

Noxafil
    Dosage: 1 df; bid;po
    Administration route: Oral
    Indication: Aspergillosis

Prednisone
    Dosage: 10 mg; qd; po
    Administration route: Oral
    Start date: 2006-10-05

Fungizone
    Dosage: 1 df; tid;po
    Administration route: Oral

Lexomil (Bromazepam)
    Dosage: 1 df;qd;po
    Administration route: Oral

Zelitrex (NO Pref. Name)
    Dosage: 500 mg;qd;po
    Administration route: Oral

Neoral
    Dosage: 50 mg;bid'po
    Administration route: Oral
    Start date: 2006-10-05

Phenoxymethylpenicillin
    Dosage: 2 df; qd

Bactrim DS
    Dosage: 1 df;tiw

Omeprazole
    Dosage: 20 mg; qd

Lederfoline (NO Pref. Name)
    Dosage: 25 mg;qw

Diantalvic (DI-Gesic)

Morphine
    Start date: 2006-12-18
    End date: 2006-12-25



Adverse event in 59 year old female receiving Noxafil (Posaconazole)

Reported by a health professional (non-physician/pharmacist) from France on 2007-03-01

Patient: 59 year old female, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Confusional State, Disorientation, Memory Impairment

Adverse event resulted in: hospitalization

Suspect drug(s):
Fungizone
    Administration route: Oral

Cortancyl
    Administration route: Oral
    Start date: 2006-10-05

Noxafil
    Administration route: Oral

Lexomil
    Administration route: Oral

Valacyclovir HCL
    Administration route: Oral

Neoral
    Administration route: Oral
    Start date: 2006-10-05

Oracilline

Bactrim DS

Omeprazole

Lederfoline

DI-Antalvic
    End date: 2006-12-25

Morphine
    End date: 2006-12-25



Adverse event in 68 year old female receiving Noxafil (Posaconazole)

Reported by a physician from Germany on 2007-02-23

Patient: 68 year old female

Adverse reactions / side effects: Acute Hepatic Failure, Haemodialysis

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Noxafil
    Dosage: 800 mg;qd;po
    Administration route: Oral
    Indication: Aspergillosis
    Start date: 2006-12-15
    End date: 2006-12-22

Noxafil
    Dosage: 800 mg;qd;po
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-12-15
    End date: 2006-12-22

Other drugs received by patient: Tavanic; Tegretol; Liskantin; Magno Sanol; Kalinor RET; Carmustine; Arac; Etoposide; Melphalan; Paliformin; Ambisome; Cancidas; Diflucan; Vfend; Acyclovir; Clexane



Adverse event in 52 year old male receiving Noxafil (Posaconazole)

Reported by a pharmacist from United States on 2007-02-20

Patient: 52 year old male

Adverse reactions / side effects: Cardiac Murmur, Dyspnoea, Rales, Hypoaesthesia, Renal Impairment, Pitting Oedema, Palpitations, Oedema Peripheral, Crepitations

Adverse event resulted in: hospitalization

Suspect drug(s):
Noxafil
    Dosage: 400mg bid po
    Administration route: Oral
    Indication: Lung Infection
    Start date: 2007-01-19
    End date: 2007-01-30

Noxafil
    Dosage: 400mg bid po
    Administration route: Oral
    Indication: Transplant
    Start date: 2007-01-19
    End date: 2007-01-30



Adverse event in female receiving Noxafil (Posaconazole)

Reported by a physician from France on 2007-01-18

Patient: female

Adverse reactions / side effects: Pancytopenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

Other drugs received by patient: Mabthera; Cyclophosphamide; Adriamycin PFS; Vincristine; Prednisone



Adverse event in female receiving Noxafil (Posaconazole)

Reported by a physician from Portugal on 2007-01-17

Patient: female

Adverse reactions / side effects: NO Adverse Drug Effect

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Noxafil (Posaconazole)

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009